Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Upadacitinib in Crohn's disease.
Dignass A, Esters P, Flauaus C. Dignass A, et al. Expert Opin Pharmacother. 2024 Mar;25(4):359-370. doi: 10.1080/14656566.2024.2333964. Epub 2024 Mar 29. Expert Opin Pharmacother. 2024. PMID: 38512115 Review.
Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study.
D'Amico F, Gomollón F, Bamias G, Magro F, Targownik L, Leitner C, Heatta-Speicher T, Michelena N, Kolterer S, Lapthorn J, Kauffman L, Dignass A; IBD PODCAST investigators. D'Amico F, et al. Among authors: dignass a. United European Gastroenterol J. 2024 Jul;12(6):705-716. doi: 10.1002/ueg2.12572. Epub 2024 May 11. United European Gastroenterol J. 2024. PMID: 38733307 Free PMC article.
Practical management of mild-to-moderate ulcerative colitis: an international expert consensus.
D'Amico F, Magro F, Dignass A, Al Awadhi S, Gutierrez Casbas A, Queiroz NSF, Rydzewska G, Duk Ye B, Ran Z, Hart A, Jairath V, Fiorino G, Peyrin-Biroulet L, Danese S. D'Amico F, et al. Among authors: dignass a. Expert Rev Gastroenterol Hepatol. 2024 Aug;18(8):421-430. doi: 10.1080/17474124.2024.2397650. Epub 2024 Sep 3. Expert Rev Gastroenterol Hepatol. 2024. PMID: 39225555 Review.
Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework.
Moreira PL, Dignass A, Estevinho MM, Portal F, Mendes J, Santiago M, Reinisch W, Sands BE, D'Haens G, Mantzaris GJ, Danese S, Peyrin-Biroulet L, Jairath V, Dotan I, Magro F; International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). Moreira PL, et al. Among authors: dignass a. United European Gastroenterol J. 2024 Nov;12(9):1280-1291. doi: 10.1002/ueg2.12679. Epub 2024 Oct 11. United European Gastroenterol J. 2024. PMID: 39391955 Free PMC article. Review.
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.
Dignass A, Van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF, Danese S, D'Hoore A, Gassull M, Gomollón F, Hommes DW, Michetti P, O'Morain C, Oresland T, Windsor A, Stange EF, Travis SP; European Crohn's and Colitis Organisation (ECCO). Dignass A, et al. J Crohns Colitis. 2010 Feb;4(1):28-62. doi: 10.1016/j.crohns.2009.12.002. Epub 2010 Jan 15. J Crohns Colitis. 2010. PMID: 21122489 No abstract available.
IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management.
Vega P, Huguet JM, Gómez E, Rubio S, Suarez P, Vera MI, Paredes JM, Hernández-Camba A, Plaza R, Mañosa M, Pajares R, Sicilia B, Madero L, Kolterer S, Leitner C, Heatta-Speicher T, Michelena N, Santos de Lamadrid R, Dignass A, Gomollón F. Vega P, et al. Among authors: dignass a. Dig Dis Sci. 2024 Mar;69(3):749-765. doi: 10.1007/s10620-023-08220-9. Epub 2024 Jan 13. Dig Dis Sci. 2024. PMID: 38217680 Free PMC article.
Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus.
Olivera PA, Dignass A, Dubinsky MC, Peretto G, Kotze PG, Dotan I, Kobayashi T, Ghosh S, Magro F, Faria-Neto JR, Siegmund B, Danese S, Peyrin-Biroulet L. Olivera PA, et al. Among authors: dignass a. Dig Liver Dis. 2024 Aug;56(8):1270-1280. doi: 10.1016/j.dld.2024.03.010. Epub 2024 Apr 6. Dig Liver Dis. 2024. PMID: 38584033 Free article. Review.
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Sands BE, D'Haens G, Clemow DB, Irving PM, Johns JT, Gibble TH, Abreu MT, Lee SD, Hisamatsu T, Kobayashi T, Dubinsky MC, Vermeire S, Siegel CA, Peyrin-Biroulet L, Moses RE, Milata J, Panaccione R, Dignass A. Sands BE, et al. Among authors: dignass a. Inflamm Bowel Dis. 2024 Oct 25:izae253. doi: 10.1093/ibd/izae253. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 39448057
322 results